2008-09-04 06:16:01 -
www.cosmederm.com - Please replace with the following corrected version due to incorrect contact information.
The corrected release reads:
COSMEDERM TECHNOLOGIES ANNOUNCES PARTNERSHIP WITH DR. REDDY'S FOR INDIAN DISTRIBUTION OF PROPRIETARY SKIN CARE PRODUCTS
Cosmederm Technologies, a US based specialty pharmaceutical company focused on dermatology and aesthetic medicine has announced a licensing and distribution agreement with Dr.
Reddy's Laboratories Ltd. (NYSE: RDY). The agreement grants Dr. Reddy's exclusive rights to distribute Cosmederm Technologies' unique skin care products throughout India.
Cosmederm's proprietary technology allows for the formulation of highly potent, non-irritating skin care products in the areas of anti-aging, acne, pruritus, rosacea and others. The partnership is for two product lines:
-- REFINITY peel kits (Glycolic acid 70%) and
-- COSMEDERM peel kits (Glycolic acid 50%)
Through this partnership Dr. Reddy's enters the aesthetic dermatology segment and consolidates its position in cosmeceuticals.
"Cosmederm's proprietary technology is exceptional in its ability to allow the formulation of highly effective skin care products. We are very excited to offer these unique products throughout the Indian market and expect the lines to quickly become leaders in the area of chemical peels and anti-aging," commented Jaspal Singh Bajwa, President, Branded Formulations Group.
"The opportunity to work with Dr. Reddy's and introduce our products to Indian consumers is a great milestone for Cosmederm. As a global brand, Dr. Reddy's is a very valuable partner," said Sean Edwards, President, Cosmederm Technologies.
Glycolic acid in higher concentrations, as it is found in the Cosmederm and Refinity lines, is:
-- known to cause epidermal peeling which improves skin tone, color and radiance
-- effective in stimulating collagen and elastin production which softens fine lines and wrinkles
-- indicated in pigmentation disorders as well as skin wrinkles
About Dr. Reddy's
Established in 1984, Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The Company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia. The Company conducts research in the areas of diabetes, cardiovascular, anti-infectives, inflammation and cancer. www.drreddys.com
About Cosmederm Technologies Inc.
Cosmederm Technologies is a specialty pharmaceutical company specializing in the development of highly potent, yet non-irritating, topical products in the areas of anti-aging, anti-itch, acne, rosacea and others. Cosmederm Technologies' product lines include TriCalm(TM), REFINITY(TM) Skin Solutions, and COSMEDERM SKIN SCIENCE(TM). www.cosmederm.com
J Public Relations
Christia Gordon, 619-255-7069 x27
christia@jpublicrelations.com 
